M

Memphasys Ltd
ASX:MEM

Watchlist Manager
Memphasys Ltd
ASX:MEM
Watchlist
Price: 0.007 AUD Market Closed
Market Cap: 18.3m AUD

Operating Margin
Memphasys Ltd

-96 278.4%
Current
-23 537%
Average
3.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-96 278.4%
=
Operating Profit
-3.6m
/
Revenue
3.7k

Operating Margin Across Competitors

No Stocks Found

Memphasys Ltd
Glance View

Memphasys Ltd. is a life sciences company. The company is headquartered in Homebush West, New South Wales. The company went IPO on 2007-05-14. The company develops medical devices, diagnostics and media with application to assists reproduction technologies in humans and animals. The Company’s lead product is Felix device. The Felix is an automated device for separating quality sperm from a semen sample for the use in human in vitro fertilization (IVF) procedures. The firm's membrane technology utilizes its separation technology along with its multiple devices and hydrogel membranes to fractionate biological molecules. The technology relies on the applied electric field and charged biological molecules. The sample and harvest chamber are formed by placing the separation membrane in between two restriction membranes with restricted pores.

MEM Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-96 278.4%
=
Operating Profit
-3.6m
/
Revenue
3.7k
What is the Operating Margin of Memphasys Ltd?

Based on Memphasys Ltd's most recent financial statements, the company has Operating Margin of -96 278.4%.

Back to Top